Cargando…
S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428229/ http://dx.doi.org/10.1097/01.HS9.0000967408.39207.65 |
| _version_ | 1785090416923639808 |
|---|---|
| author | Dokal, Arran Borek, Weronika E. Nobre, Luis Federico Pedicona, Salvatore Wrench, Bela Gallipoli, Paolo Arruda, Andrea Campbell, Amy E. Nawaz, Nazrath Ferguson, Harriet R. Perkins, David N. Moreno-Cardoso, Pedro Thompson, Andrew Williamson, Andrew J.K. Minden, Mark D. Gribben, John G. Britton, David J. Cutillas, Pedro R. |
| author_facet | Dokal, Arran Borek, Weronika E. Nobre, Luis Federico Pedicona, Salvatore Wrench, Bela Gallipoli, Paolo Arruda, Andrea Campbell, Amy E. Nawaz, Nazrath Ferguson, Harriet R. Perkins, David N. Moreno-Cardoso, Pedro Thompson, Andrew Williamson, Andrew J.K. Minden, Mark D. Gribben, John G. Britton, David J. Cutillas, Pedro R. |
| author_sort | Dokal, Arran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428229 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104282292023-08-17 S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA Dokal, Arran Borek, Weronika E. Nobre, Luis Federico Pedicona, Salvatore Wrench, Bela Gallipoli, Paolo Arruda, Andrea Campbell, Amy E. Nawaz, Nazrath Ferguson, Harriet R. Perkins, David N. Moreno-Cardoso, Pedro Thompson, Andrew Williamson, Andrew J.K. Minden, Mark D. Gribben, John G. Britton, David J. Cutillas, Pedro R. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428229/ http://dx.doi.org/10.1097/01.HS9.0000967408.39207.65 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Dokal, Arran Borek, Weronika E. Nobre, Luis Federico Pedicona, Salvatore Wrench, Bela Gallipoli, Paolo Arruda, Andrea Campbell, Amy E. Nawaz, Nazrath Ferguson, Harriet R. Perkins, David N. Moreno-Cardoso, Pedro Thompson, Andrew Williamson, Andrew J.K. Minden, Mark D. Gribben, John G. Britton, David J. Cutillas, Pedro R. S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA |
| title | S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA |
| title_full | S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA |
| title_fullStr | S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA |
| title_full_unstemmed | S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA |
| title_short | S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA |
| title_sort | s124: phosphoproteomics accurately predicts responses to midostaurin plus chemotherapy in two independent cohorts of flt3 mutant-positive acute myeloid leukaemia |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428229/ http://dx.doi.org/10.1097/01.HS9.0000967408.39207.65 |
| work_keys_str_mv | AT dokalarran s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT borekweronikae s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT nobreluis s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT federicopediconasalvatore s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT wrenchbela s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT gallipolipaolo s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT arrudaandrea s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT campbellamye s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT nawaznazrath s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT fergusonharrietr s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT perkinsdavidn s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT morenocardosopedro s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT thompsonandrew s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT williamsonandrewjk s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT mindenmarkd s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT gribbenjohng s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT brittondavidj s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia AT cutillaspedror s124phosphoproteomicsaccuratelypredictsresponsestomidostaurinpluschemotherapyintwoindependentcohortsofflt3mutantpositiveacutemyeloidleukaemia |